Live Breaking News & Updates on Cidara Therapeutic
Stay updated with breaking news from Cidara therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Steven Cohen (Trades, Portfolio)'s investment firm, Point72, has recently expanded its portfolio with the addition of Cidara Therapeutics Inc (NASDAQ:CDTX). On December 31, 2023, Point72 acquired 1,250,228 shares of the biotechnology company, reflecting a new position in the firm's diverse investment landscape. The transaction was executed at a trade price of $0.794 per share, marking a strategic move by one of the industry's leading investment entities. ....
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Free Report) – Investment analysts at HC Wainwright decreased their Q3 2023 EPS estimates for Cidara Therapeutics in a research note issued to investors on Monday, August 7th. HC Wainwright analyst E. Arce now expects that the biotechnology company will post earnings per share of ($0.14) for the quarter, down […] ....